Vaccine shows therapeutic promise against advanced melanoma

A vaccine for one of the most lethal cancers, advanced melanoma, has shown improved response rates and progression-free survival for patients when combined with the immunotherapy drug, Interleukin-2, according to researchers from The University of Texas M. D. Anderson Cancer Center.

If you want to include this story in your blog, copy and paste this formatted text:

<p><a href="http://www.physorg.com/news163071438.html">Vaccine shows therapeutic promise against advanced melanoma</a></p> <p>A vaccine for one of the most lethal cancers, advanced melanoma, has shown improved response rates and progression-free survival for patients when combined with the immunotherapy drug, Interleukin-2, according to researchers from The University of Texas M. D. Anderson Cancer Center.</p>